NFKB1 and liver disorder: Considerable evidence suggests that TNF-α and IL-1β contribute to the pathogenesis of liver inflammatory diseases by activating the NF-κB signaling pathway [27], suggesting that it may be important to monitor proinflammatory cytokines when studying liver injury.